A world without Vioxx: To COX-2 or not to COX-2?

Article Type
Changed
Mon, 10/08/2018 - 15:30
Display Headline
A world without Vioxx: To COX-2 or not to COX-2?
Article PDF
Author and Disclosure Information

Lee S. Simon, MD
Associate Clinical Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA

Vibeke Strand, MD
Adjunct Clinical Professor of Medicine, Stanford University School of Medicine, Stanford, CA

Address: Lee S. Simon, MD, Associate Clinical Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Suite 4B, Boston, MA; e-mail [email protected]

Dr. Simon has indicated that he has been an investigator and consultant for and has received honoraria from GD Searle, Pharmacia, and Pfizer. He serves as a consultant in drug development for TAP Pharmaceuticals, Sanofi Aventis, AlphaRx, Synta Pharmaceuticals, Roche, Millenium, Cypress, Forrest, Pierre Fabre, Omeros, and Pfizer.

Dr. Strand has indicated that she has worked as an independent consultant for Abbott Immunology, Abgenix, Amgen, Biogen Idec, Celltech, Centocor, Enzon, Genelabs, Genentech, Hoffman, Incyte, La Jolla Pharmaceuticals, Millenium, Novartis, Omeros, Organon, Pfizer Research, Sanofi Aventis, Scios, Serono, SKK, and Sumitomo corporations. She has served on advisory boards for Abbott, Abgenix, Amgen, Aventis, Centocor, Lilly, RWJ Pharmaceutical Research Institute, Roche, Novartis, and Pfizer. She serves on the speakers’ bureaus for Abbott, Amgen, Sanofi Aventis, and Pfizer.

Issue
Cleveland Clinic Journal of Medicine - 71(11)
Publications
Topics
Page Number
849-850, 852, 854, 856
Sections
Author and Disclosure Information

Lee S. Simon, MD
Associate Clinical Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA

Vibeke Strand, MD
Adjunct Clinical Professor of Medicine, Stanford University School of Medicine, Stanford, CA

Address: Lee S. Simon, MD, Associate Clinical Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Suite 4B, Boston, MA; e-mail [email protected]

Dr. Simon has indicated that he has been an investigator and consultant for and has received honoraria from GD Searle, Pharmacia, and Pfizer. He serves as a consultant in drug development for TAP Pharmaceuticals, Sanofi Aventis, AlphaRx, Synta Pharmaceuticals, Roche, Millenium, Cypress, Forrest, Pierre Fabre, Omeros, and Pfizer.

Dr. Strand has indicated that she has worked as an independent consultant for Abbott Immunology, Abgenix, Amgen, Biogen Idec, Celltech, Centocor, Enzon, Genelabs, Genentech, Hoffman, Incyte, La Jolla Pharmaceuticals, Millenium, Novartis, Omeros, Organon, Pfizer Research, Sanofi Aventis, Scios, Serono, SKK, and Sumitomo corporations. She has served on advisory boards for Abbott, Abgenix, Amgen, Aventis, Centocor, Lilly, RWJ Pharmaceutical Research Institute, Roche, Novartis, and Pfizer. She serves on the speakers’ bureaus for Abbott, Amgen, Sanofi Aventis, and Pfizer.

Author and Disclosure Information

Lee S. Simon, MD
Associate Clinical Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA

Vibeke Strand, MD
Adjunct Clinical Professor of Medicine, Stanford University School of Medicine, Stanford, CA

Address: Lee S. Simon, MD, Associate Clinical Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Suite 4B, Boston, MA; e-mail [email protected]

Dr. Simon has indicated that he has been an investigator and consultant for and has received honoraria from GD Searle, Pharmacia, and Pfizer. He serves as a consultant in drug development for TAP Pharmaceuticals, Sanofi Aventis, AlphaRx, Synta Pharmaceuticals, Roche, Millenium, Cypress, Forrest, Pierre Fabre, Omeros, and Pfizer.

Dr. Strand has indicated that she has worked as an independent consultant for Abbott Immunology, Abgenix, Amgen, Biogen Idec, Celltech, Centocor, Enzon, Genelabs, Genentech, Hoffman, Incyte, La Jolla Pharmaceuticals, Millenium, Novartis, Omeros, Organon, Pfizer Research, Sanofi Aventis, Scios, Serono, SKK, and Sumitomo corporations. She has served on advisory boards for Abbott, Abgenix, Amgen, Aventis, Centocor, Lilly, RWJ Pharmaceutical Research Institute, Roche, Novartis, and Pfizer. She serves on the speakers’ bureaus for Abbott, Amgen, Sanofi Aventis, and Pfizer.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 71(11)
Issue
Cleveland Clinic Journal of Medicine - 71(11)
Page Number
849-850, 852, 854, 856
Page Number
849-850, 852, 854, 856
Publications
Publications
Topics
Article Type
Display Headline
A world without Vioxx: To COX-2 or not to COX-2?
Display Headline
A world without Vioxx: To COX-2 or not to COX-2?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media